0000950170-24-065598.txt : 20240528
0000950170-24-065598.hdr.sgml : 20240528
20240528205933
ACCESSION NUMBER: 0000950170-24-065598
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: MARAVAI LIFESCIENCES HOLDINGS, INC.
CENTRAL INDEX KEY: 0001823239
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39725
FILM NUMBER: 24993783
BUSINESS ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 546-0004
MAIL ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: MARAVAI LIFE SCIENCES HOLDINGS 2, LLC
CENTRAL INDEX KEY: 0001832794
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
BUSINESS ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 546-0004
MAIL ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
144
1
primary_doc.xml
144
0001832794
XXXXXXXX
LIVE
0001823239
MARAVAI LIFESCIENCES HOLDINGS, INC.
001-39725
10770 Wateridge Circle
Suite 200
San Diego
CA
92121
858-546-0004
Maravai Life Sciences Holdings 2, LLC
Owner
Class A common stock, par value $0.01 per share
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
1531028
16504481.84
132830872
05/28/2024
Nasdaq
Class A common stock, par value $0.01 per share
11/19/2020
Pre-IPO reorganization
Maravai LifeSciences Holdings, Inc.
N
28965664
11/19/2020
Securities of the issuer were received in connection with a series of reorganization transactions prior to the issuer's IPO.
Y
(1) Based on the closing price on May 28, 2024 of $10.78. (2) As of May 2, 2024 (as reported on the Issuer's Form 10-Q for the quarter ended March 31, 2024, filed with the Securities and Exchange Commission on May 9, 2024).
05/28/2024
/s/ Kevin Herde